News

News

Patent eligibility reform ‘top priority,’ Tillis says in US Senate hearing

News

PERA 2025 Debated in Senate IP Subcommittee Hearing, with Business Methods, Diagnostics in Focus

News

US Senate continues uphill battle on patent eligibility bill

News

How impactful is the new USPTO director’s S101 decision?

News

Amgen Attacks Academics’ False Claims About Biologic Patents

News

C4IP Publishes Website Addressing Misinformation Published by I-MAK

News

USPTO gets new director as John Squires secures Senate confirmation

News

Senate Confirms Squires To Lead USPTO

News

China pharma deals threaten U.S. biotech

News

C4IP Urges FTC to Proceed with Caution on Addressing Perceived Drug Pricing Problems

Scroll to Top